相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prognostic significance of overexpression and phosphorylation of epidermal growth factor receptor (EGFR) and the presence of truncated EGFRvIII in locoregionally advanced breast cancer
Yago Nieto et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Identification of candidate molecular markers predicting sensitivity in solid tumors to dasatinib: Rationale for patient selection
Fei Huang et al.
CANCER RESEARCH (2007)
Predictors of resistance to preoperative trastuzumab and vinorelbine for HER2-positive early breast cancer
Lyndsay N. Harris et al.
CLINICAL CANCER RESEARCH (2007)
Protein expression profiling in high-risk breast cancer patients treated with high-dose or conventional dose-dense chemotherapy
Raihanatou Diallo-Danebrock et al.
CLINICAL CANCER RESEARCH (2007)
Molecular classification of breast cancer: implications for selection of adjuvant chemotherapy
Fabrice Andre et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2006)
Concordance among gene-expression-based predictors for breast cancer
Cheng Fan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer
Soonmyung Paik et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Efficacy of high-dose alkylating chemotherapy in HER2/neu-negative breast cancer
S Rodenhuis et al.
ANNALS OF ONCOLOGY (2006)
Vascular endothelial growth factor messenger RNA expression level is preserved in liver metastases compered with corresponding primary colorectal cancer
H Kuramochi et al.
CLINICAL CANCER RESEARCH (2006)
Tumor gene expression and prognosis in breast cancer patients with 10 or more positive lymph nodes
MA Cobleigh et al.
CLINICAL CANCER RESEARCH (2005)
Comparison of rapidly cycled tandem high-dose chemotherapy plus peripheral-blood stem-cell support versus dose-dense conventional chemotherapy for adjuvant treatment of high-risk breast cancer:: results of a multicentre phase III trial
UA Nitz et al.
LANCET (2005)
Effect of screening and adjuvant therapy on mortality from breast cancer
DA Berry et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer
L Gianni et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Breast cancer molecular subtypes respond differently to preoperative chemotherapy
R Rouzier et al.
CLINICAL CANCER RESEARCH (2005)
Microtubule-associated protein tau: A marker of paclitaxel sensitivity in breast cancer
R Rouzier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Gene expression profiling of breast cancer: A new tumor marker
LJ van't Veer et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
S Paik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Prognostic indicators and survival in patients with stage IIIB inflammatory breast carcinoma after dose intense chemotherapy
G Somlo et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Staging system for breast cancer:: revisions for the 6th edition of the AJCC Cancer Staging Manual
SE Singletary et al.
SURGICAL CLINICS OF NORTH AMERICA (2003)
Repeated observation of breast tumor subtypes in independent gene expression data sets
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: First report of intergroup trial C9741/cancer and leukemia group B trial 9741
ML Citron et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer
IC Henderson et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
A gene-expression signature as a predictor of survival in breast cancer.
MJ van de Vijver et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Predictors of long-term outcome following high-dose chemotherapy in high-risk primary breast cancer
G Somlo et al.
BRITISH JOURNAL OF CANCER (2002)
Evaluation of the predictive value of Her-2/neu overexpression and p53 mutations in high-risk primary breast cancer patients treated with high-dose chemotherapy and autologous stem-cell transplantation
Y Nieto et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence
RVN Lord et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2000)
分享论文
